David Vodak

David Vodak is the Chief Science Officer at CoreRx, Inc. and Bend Bioscience, where they apply their extensive expertise in pharmaceutical R&D. Previously, they held roles such as Senior Director of Pharmaceutical R&D at Capsugel and Senior Director, Head of Small Molecules R&D at Lonza, focusing on innovative drug development and delivery technologies. Vodak has also served as a Senior Consultant and has a solid academic foundation, holding a Ph.D. in Materials Science from the University of Michigan and a postdoctoral fellowship in Physical Chemistry from The Scripps Research Institute.